ストックスクリーナーアプリを入手
97.20
0.86%
-0.84
アフターアワーズ：
97.11
-0.09
-0.09%
前日終値:
$98.04
開ける：
$98.23
24時間の取引高:
88,908
Relative Volume:
0.67
時価総額：
$1.24B
収益：
$86.28M
当期純損益:
$23.61M
株価収益率:
52.94
EPS:
1.8359
ネットキャッシュフロー:
$23.97M
1週間 パフォーマンス:
-3.73%
1か月 パフォーマンス:
+1.25%
6か月 パフォーマンス:
-1.77%
1年 パフォーマンス:
+63.44%
1日の値動き範囲:
$97.11
$98.64
1週間の範囲:
$95.12
$102.99
52週間の値動き範囲:
$55.11
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
97.20 | 1.24B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-04-12 | 開始されました | Lake Street | Buy |
| 2017-10-31 | 再開されました | ROTH Capital | Buy |
| 2016-10-05 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2015-11-02 | 繰り返されました | ROTH Capital | Buy |
| 2015-07-30 | 繰り返されました | ROTH Capital | Buy |
| 2015-06-16 | 繰り返されました | ROTH Capital | Buy |
| 2015-01-12 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-23 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Iradimed Corp (IRMD) 最新ニュース
Price to book forward of IRadimed Corp. – LS:A118V4 - TradingView
IRMDIradimed Corp Latest SEC Filings - Finviz
Price to book forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to EBITDA forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to revenue forward of IRadimed Corp. – HAN:46K - TradingView
IRadimed Corp. Actuals & Estimates (DUS:46K) - TradingView
IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD) - TradingView
46K Forecast — Price Target — Prediction for 2027 - TradingView
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRADIMED Corporation Form 8-K Filing Summary: Company Details and NASDAQ Listing Information (June 24, 2026) - Minichart
Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay - Stock Titan
IRADIMED CORP (IRMD) Stock Chart - ChartMill
Form 4 Iradimed Co For: 23 June By Investing.com - Investing.com Australia
IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes - Stock Titan
IRadimed Corp (IRMD) Institutional Confidence - TradingKey
IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative - Sahm
IRMD Technical Analysis & Stock Price Forecast - Intellectia AI
IRadimed Corp (IRMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Number of shareholders of IRadimed Corp. – DUS:46K - TradingView
Iradimed director sells $285,000 in company stock By Investing.com - Investing.com Australia
Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD) - GuruFocus
Iradimed director sells $285,000 in company stock - Investing.com UK
IRADIMED (IRMD) director sells 3,000 shares in open-market trades - Stock Titan
IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares - Stock Titan
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple - Yahoo Finance
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan - Stock Titan
IRADIMED CEO Sells 7500 Common Stock Shares - asatunews.co.id
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - The Motley Fool
Iradimed Corp Quarterly Report Highlights Key Growth DriversEarnings Call Q&A - The Legal Advocate
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
Iradimed Corp Reports Q1 Earnings: Three Key Areas to WatchProfit Announcement - newsline.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report - Insider Monkey
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? - sharewise.com
iRadimed (IRMD) Slips Amidst Sector Headwinds: Key Levels in FocusSweep Order Flow - The Legal Advocate
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed Corp (IRMD) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
大文字化:
|
ボリューム (24 時間):